Elon Musk’s Neuralink taps FDA regulator who led division overseeing the startup

Elon Musk’s brain implant company Neuralink has tapped a top U.S. health regulator responsible for overseeing the company and its competitors, according to a company announcement. U.S. FDA executive David McMullen will lead Neuralink’s medical affairs division, according to the company’s website, a prominent appointment that calls into question the Trump administration’s promise to end the revolving door of government regulators moving into the private sector.